Esperion Therapeutics Inc (NAS:ESPR)
$ 2.8 0.33 (13.36%) Market Cap: 530.49 Mil Enterprise Value: 572.87 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Esperion Therapeutics Inc at Jefferies London Healthcare Conference Transcript

Nov 14, 2023 / 08:00AM GMT
Release Date Price: $1.09 (+15.28%)
Dennis Ding
Jefferies LLC. - Analyst

Good morning, everybody. My name is Dennis Ding, biotech analyst here at Jefferies. Welcome to the 2023 London Healthcare Conference. I have the great pleasure of having CEO, Sheldon Koenig of Esperion, here with us today. It's great to see you in person, Sheldon. And it's great to see all investors in the room this morning as well.

Questions & Answers

Dennis Ding
Jefferies LLC. - Analyst

So maybe to level set all of those, just remind us of all the progress you guys have made this year and how you think about the outlook for bempedoic acid going forward.

Sheldon Koenig
Esperion Therapeutics, Inc. - President & CEO

Great. Thank you, Dennis. And not be rude, I'll look at the audience while I speak. First of all, I just want to thank Jefferies on behalf of all employees at Esperion for inviting us here to this conference.

And as related to bempedoic acid, as I was just saying to Dennis outside of the room, we're super excited of the progress that we've

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot